Thus, the IL-23/Th17 signalling pathway, consisting of IL-23/IL-23R, IL-17A and IL-17F encoding genes, represents a candidate way for RA development with possible involvement in disease susceptibility and effect on disease progression (Iwakura and Ishigame 2006; Lubberts 2010). The gene discussed is IL17F; the disease is rheumatoid arthritis.